Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle bulge cells don't help skin regrow after glucocorticoid damage; interfollicular epidermis cells do.

The rapid corticotropin test is a quick and simple way to diagnose adrenal insufficiency.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

New techniques have improved acne scar treatment, but multiple tailored sessions are often needed.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

miR-22, a type of microRNA, controls hair growth and its overproduction can cause hair loss, while its absence can speed up hair growth.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Finasteride can cause serious side effects in some men, needing more research for treatment.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

An unhealthy scalp can damage new hair, but using ZPT shampoo can improve hair health.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Post-finasteride syndrome causes sexual, physical, and psychological symptoms, but more research is needed to understand its causes and connection to finasteride.

Post-void residual volume does not predict worsening urological symptoms in multiple sclerosis patients.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

Finasteride may cause vitiligo, sexual issues, and depression; better treatments and predicting side effects needed.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Finasteride and dutasteride can cause severe, lasting side effects.

Elderly men with a scalp condition healed in about 26 days using specific creams and dressings, with no return of the condition in 6 months.

Post-finasteride syndrome's existence is uncertain; more research needed.

Finasteride can cause serious physical, mental, and sexual side effects, even after stopping the treatment.

Finasteride for female hair loss has low side effects, more research needed.

Post-finasteride syndrome causes lasting sexual, mental, and physical issues, needing more research for solutions.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.